CD86 and neoplasm: Furthermore, higher levels of CD86 on tumor‐infiltrating cDC2s upon TLR stimulation (R848 or mix) were linked with a worse clinical outcome both for PFS and OS from sampling time (Supplementary figures 4f, 5b).